Position in Pfizer Reduced

By on November 25, 2019

stock market sectorsWhen individual stock positions reach an allocation of 3.5% of the SMA Portfolio the position will be trimmed to a level closer to 3%. The position in Pfizer (PFE) was reduced today to comply with this new rule.

Approximately 15% of the position in Pfizer was sold at $38.80 today.

Disclaimer: It is very challenging to outperform a buy and hold strategy. Historically, investors have found themselves well-served over the long-term by investing regularly in a diversified portfolio of stocks or low cost, broadly diversified indexed stock funds. Information presented is based on analysis of past data and assessments by the Tactical Timing System model. Future performance may not reflect past performance. Profitable trades are not guaranteed. No system or methodology ensures stock market profits. Although accuracy is strived for, no guarantee is made regarding the accuracy of data presented.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>